News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
Helena Sen
Controller
Ms. Sen joined Burrill & Company in 2001. Previously she was the Controller for two Bay Area start ups in the healthcare sector: OnCare, Inc., an oncology physician practice management company, and Axion Inc. an oncology drug distributor. Previously Ms. Sen was an Audit Manager at BDO Seidman. She obtained her CPA while at Laventhol & Horwath where she was an Audit Supervisor responsible for a diverse range of audit engagements.
Ms. Sen received a BS in Accounting from the University of San Francisco.


